A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
Status:
Completed
Trial end date:
2009-02-12
Target enrollment:
Participant gender:
Summary
This study was performed to evaluate the local and systemic safety profile and the analgesic
efficacy of long-term treatment with lidocaine 5% medicated plaster (Lido-Patch).
The study was an open-label, multi-center, multiple-dose, Phase III study and comprised a
main and an extension period. 161 participants who completed treatment in KF10004/01
(NCT03745404) and 98 newly recruited participants were enrolled.